AN2728 ointment, 2%

DRUG3 trials

Sponsors

Pfizer

Conditions

Dermatitis, AtopicPsoriasis

Phase 1

A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

CompletedNCT00762658

PfizerPsoriasis

Start: 2007-11-30End: 2007-12-07Updated: 2019-02-22

Phase 2

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

CompletedNCT01300052

PfizerPsoriasis

Start: 2011-01-26End: 2011-06-06Updated: 2017-04-17

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

CompletedNCT01301508

PfizerDermatitis, Atopic

Start: 2011-05-31End: 2011-11-11Updated: 2019-02-22